Delta Investment Management’s Maravai LifeSciences MRVI Stock Holding History

Delta Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-307,371	Closed	-$870K	–	310
2026 Q1	$870K	Sell	307,371 -108,229	-26%	-$367K	0.16%	104
2025 Q4	$1.35M	Sell	415,600 -54,540	-12%	-$184K	0.23%	78
2025 Q3	$1.35M	Sell	470,140 -39,801	-8%	-$102K	0.24%	74
2025 Q2	$1.23M	Buy	509,941 +66,252	+15%	+$139K	0.24%	76
2025 Q1	$981K	Buy	443,689 +110,696	+33%	+$437K	0.2%	70
2024 Q4	$1.81M	Buy	332,993 +246,592	+285%	+$1.59M	0.35%	50
2024 Q3	$718K	Buy	+86,401	New	+$747K	0.15%	91

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Delta Investment Management's MRVI Position: Q2 2026 in Review

Delta Investment Management sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 307,371 shares — an estimated $870K sold.

Delta Investment Management first reported a position in MRVI in Q3 2024 and held it in 7 quarters. The position peaked at $1.81M in Q4 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Delta Investment Management reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
Delta Investment Management sold 307,371 Maravai LifeSciences shares in Q2 2026, an estimated $870K.
Delta Investment Management first reported a position in Maravai LifeSciences in Q3 2024 and held it in 7 quarters.
Delta Investment Management's Maravai LifeSciences position peaked at $1.81M in Q4 2024.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Delta Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.